These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 9182107)

  • 1. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
    Klemens SP; DeStefano MS; Cynamon MH
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2413-7. PubMed ID: 1336945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
    Fattorini L; Li B; Piersimoni C; Tortoli E; Xiao Y; Santoro C; Ricci ML; Orefici G
    Antimicrob Agents Chemother; 1995 Mar; 39(3):680-5. PubMed ID: 7793873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    FEMS Immunol Med Microbiol; 1999 Jan; 23(1):37-44. PubMed ID: 10030545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial synergism of clarithromycin and rifabutin.
    Ghebremichael S; Svenson SB; Källenius G; Hoffner SE
    Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
    Bakker-Woudenberg IA; van Vianen W; van Soolingen D; Verbrugh HA; van Agtmael MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2387-98. PubMed ID: 15917538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex.
    Piersimoni C; Tortoli E; Mascellino MT; Passerini Tosi C; Sbaraglia G; Mandler F; Bistoni F; Bornigia S; De Sio G; Goglio A
    J Antimicrob Chemother; 1995 Sep; 36(3):497-502. PubMed ID: 8830013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
    Tomioka H; Sano C; Sato K; Shimizu T
    Int J Antimicrob Agents; 2002 Feb; 19(2):139-45. PubMed ID: 11850167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
    Reisner BS; Woods GL; Popov VL
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):270-5. PubMed ID: 9432376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.
    Lounis N; Ji B; Truffot-Pernot C; Grosset J
    Antimicrob Agents Chemother; 1995 Mar; 39(3):608-12. PubMed ID: 7793860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W
    BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.
    Ellis LC; Benson CA; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2803-6. PubMed ID: 8593025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.